Sciele Pharma expects to launch six new products in 2008, executives announced, including a new formulation of its blood pressure drug Sular and two forms of the Prandin drug for Type II diabetes, plus at least two meds awaiting FDA approval. Release
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.
